Лучшие больницы для «Vaginal Hysterectomy» в Дели (NCR), Индия

The uterus is a hormone-responsive, muscular pelvic organ whose pathological changes — including symptomatic uterine fibroids, adenomyosis, uterine prolapse, endometrial hyperplasia, chronic pelvic pain, and early-stage gynecological malignancies — can profoundly impair a woman's quality of life, fertility intentions, urinary continence, and overall pelvic floor integrity. When medical management (hormonal therapy, levonorgestrel-releasing intrauterine systems, GnRH agonists such as leuprolide acetate, or uterine artery embolisation) fails or is contraindicated, surgical removal of the uterus — hysterectomy — remains the definitive treatment. Globally, hysterectomy is one of the most commonly performed major gynaecological surgeries, and the vaginal route is endorsed by the American College of Obstetricians and Gynecologists (ACOG) and the Royal College of Obstetricians and Gynaecologists (RCOG) as the preferred approach when anatomically feasible, owing to its superior safety profile and recovery advantages.

Eligible CANDIDATES:

• Women with symptomatic uterine fibroids (leiomyomas) unresponsive to medical therapy, with uterine size ≤12–14 weeks gestation (relative guide)
• Adenomyosis causing menorrhagia, dysmenorrhoea, or chronic pelvic pain refractory to hormonal management
• Uterine prolapse (Stage II–IV per POP-Q classification), particularly when concurrent pelvic floor repair is planned
• Endometrial hyperplasia with atypia or low-grade endometrial carcinoma (FIGO Stage IA) where vaginal approach is feasible
• Dysfunctional uterine bleeding uncontrolled by endometrial ablation, Mirena IUS, or hormonal therapy
• +3 more

Required Pre-operative DIAGNOSTICS:

Surgical Approaches TO Hysterectomy — Comparative OVERVIEW:

1. TRADITIONAL VAGINAL HYSTERECTOMY (TVH) The gold-standard vaginal approach involves a circumferential colpotomy incision at the cervicovaginal junction, sequential clamping, cutting, and suture ligation of the uterosacral and cardinal ligaments (parametria), uterine arteries, and upper pedicles (round ligament, fallopian tube, ovarian ligament). The uterus is delivered in toto or, if enlarged, by surgical debulking using intramyometrial coring, bisection (Heaney technique), or wedge morcellation — all performed vaginally. The vaginal vault is closed with absorbable sutures (polyglactin 910 or barbed suture), and McCall culdoplasty or uterosacral ligament suspension is performed to prevent future vault prolapse. Advantages: no abdominal incisions, lowest complication rate in suitable patients, cost-effective.

2. LAPAROSCOPICALLY ASSISTED VAGINAL HYSTERECTOMY (LAVH) Laparoscopic ports (typically one 10 mm umbilical and two 5 mm lateral trocars) allow the surgeon to use CO2 pneumoperitoneum to inspect the pelvis, lyse adhesions, treat endometriosis implants, and divide the adnexa and upper uterine pedicles using advanced energy devices (LigaSure™ vessel sealing system, Harmonic Ace+7™ ultrasonic shears). The remainder of the procedure is completed vaginally. LAVH is preferred when adnexal pathology, adhesions from prior caesarean sections, or mild-to-moderate endometriosis is present. Blood loss and conversion rates are significantly reduced.

3. TOTAL LAPAROSCOPIC HYSTERECTOMY WITH VAGINAL EXTRACTION (TLH) The entire procedure — including uterine artery coagulation, colpotomy, and pedicle division — is performed laparoscopically using 3D high-definition (HD) or 4K camera systems and articulating instruments. The uterus is extracted vaginally after complete laparoscopic dissection. Robotic-assisted TLH using the da Vinci Xi or da Vinci SP surgical systems provides 7-degree-of-freedom wristed instrument motion, superior ergonomics, and enhanced visualisation in narrow pelvises or after prior pelvic surgery. This is particularly advantageous in patients with BMI >35, prior multiple abdominal surgeries, or complex endometriosis.

PRE-OPERATIVE PHASE (4–6 weeks before surgery):

• Remote consultation with GAF Healthcare's partner gynaecologist: review of medical records, imaging (MRI/TVUS), biopsy reports, and surgical planning
• Pre-operative optimisation: iron therapy for anaemia (IV iron sucrose infusion if haemoglobin <10 g/dL), GnRH agonist (depot leuprolide 3.75 mg IM) may be prescribed 4–8 weeks pre-operatively to reduce fibroid volume and control bleeding
• Travel and visa documentation coordinated by GAF Healthcare case manager
• Arrival in India or UAE: 2–3 days before surgery for in-person pre-operative assessment, anaesthesia review, repeat blood work, and consent
• Bowel preparation: mechanical bowel preparation is generally NOT required under modern ERAS protocols; a light diet and overnight fast suffice
• Antibiotic prophylaxis: IV Cefazolin 2g (or Clindamycin if penicillin-allergic) administered 30–60 minutes before incision
• DVT prophylaxis: low-molecular-weight heparin (enoxaparin 40 mg SC) commenced pre-operatively and continued post-operatively; graduated compression stockings applied

INTRAOPERATIVE PHASE (Duration: 60–180 minutes depending on approach and complexity):